118
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma

, &
Pages 1621-1628 | Published online: 09 Nov 2021

References

  • Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7– 9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005;22(5):383–406. doi:10.1111/j.1525-1470.2005.00102.x
  • Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011;28(6):663–669. doi:10.1111/j.1525-1470.2011.01568.x
  • Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol. 2011;25(11):1254–1260. doi:10.1111/j.1468-3083.2011.04105.x
  • Tay YK, Tan SK. Treatment of infantile hemangiomas with the 595-nm pulsed dye laser using different pulse widths in an Asian population. Lasers Surg Med. 2012;44(2):93–96. doi:10.1002/lsm.21159
  • Zhang W, Li F, Yang Y, et al. Hemangioma treatment with pulsed dye laser-distinct parameters used between neonatal and non-neonatal patients. J Cosmet Laser Ther. 2016;18(7):389–392. doi:10.1080/14764172.2016.1197402
  • Zheng L, Li Y. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis. Arch Dermatol Res. 2018;310(4):261–269. doi:10.1007/s00403-018-1815-y
  • Feng H, Kauvar ANB. Successful treatment of a residual, thick, infantile hemangioma in a darker phototype pediatric patient using the 755-nm long-pulsed alexandrite laser. Dermatol Surg. 2017;43(12):1514–1516. doi:10.1097/DSS.0000000000001144
  • Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HPW. Verrucous hemangioma revisited. Pediatr Dermatol. 2006;23(3):208–215. doi:10.1111/j.1525-1470.2006.00219.x
  • Su WT, Xue JX, Ke YH. Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: a case report and literature review. World J Clin Cases. 2019;7(14):1876–1883. doi:10.12998/wjcc.v7.i14.1876
  • Ashinoff R, Geronemus RG. Failure of the flashlamp-pumped pulsed dye laser to prevent progression to deep hemangioma. Pediatr Dermatol. 1993;10(1):77–80. doi:10.1111/j.1525-1470.1993.tb00021.x
  • Poetke M, Philipp C, Berlien HP. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000;136(5):628–632. doi:10.1001/archderm.136.5.628
  • Hartmann F, Lockmann A, Grönemeyer LL, et al. Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children. J Eur Acad Dermatol Venereol. 2017;31(8):1372–1379. doi:10.1111/jdv.14074
  • Alcántara-González J, Boixeda P, Truchuelo-Diez MT, et al. Infantile hemangiomas treated by sequential application of pulsed dye laser and Nd: YAG laser radiation: a retrospective study. Actas Dermosifiliogr. 2013;104(6):504–511.
  • Bastos JT, Balassiano LK, Mariano da Rocha CR, et al. Treatment of vascular lesions located in the lip and in the oral cavity with Nd: YAG laser. J Cosmet Laser Ther. 2017;19(5):256–258. doi:10.1080/14764172.2017.1314503
  • Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–746. doi:10.1056/NEJMoa1404710
  • Baselga E, Dembowska-Baginska B, Przewratil P, et al. Efficacy of propranolol between 6 and 12 months of age in high-risk infantile hemangioma. Pediatrics. 2018;142(3):e20173866.
  • Kim KH, Choi TH, Choi Y, et al. Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma: a randomized clinical trial. JAMA Dermatol. 2017;153(6):529–536. doi:10.1001/jamadermatol.2017.0250
  • Wu HW, Wang X, Zhang L, et al. Topical timolol vs. oral propranolol for the treatment of superficial infantile hemangiomas. Front Oncol. 2018;8:605. doi:10.3389/fonc.2018.00605
  • Izikson L, Anderson RR. Treatment endpoints for resistant port wine stains with a 755nm laser. J Cosmet Laser Ther. 2009;11(1):52–55. doi:10.1080/14764170802524452
  • Jin -W-W, Tong Y, Wu J-M, Quan -H-H, Gao Y. Observation on the effects of 595- nm pulsed dye laser and 755- nm long-pulsed alexandrite laser on sequential therapy of infantile hemangioma. J Cosmet Laser Ther. 2020;22(3):1–6.
  • Su W, Ke Y, Xue J. Beneficial effects of early treatment of infantile hemangiomas with a long-pulse Alexandrite laser. Lasers Surg Med. 2014;46(3):173–179. doi:10.1002/lsm.22221
  • Hemangioma and Vascular Malformation Group. Guidelines for the diagnosis and treatment of hemangioma and vascular malformations (2019 edition). J Tissue Eng Reconstr Surg. 2019;15(5):277–317.
  • McCormack HM, de L. Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18(4):1007–1019. doi:10.1017/S0033291700009934
  • Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–527. doi:10.1126/science.6836297
  • Wang F, Xu R, Xu Q, et al. Effect of laser therapy on plasma expression of VEGF and bFGF in infants with cutaneous hemangioma. Oncol Lett. 2017;13(3):1861–1865. doi:10.3892/ol.2017.5640
  • Chang J, Most D, Bresnick S, et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg. 1999;103(1):1–9; discussion 10. doi:10.1097/00006534-199901000-00001
  • Bruscino N, Bonan P, Cannarozzo G, et al. Laser use in infantile hemangiomas, when and how. Dermatol Ther. 2012;25(4):314–321. doi:10.1111/j.1529-8019.2012.01466.x
  • Goh CL. Flashlamp-pumped pulsed dye laser (585nm) for the treatment of portwine stains–a study of treatment outcome in 94 Asian patients in Singapore. Singapore Med J. 2000;41(1):24–28.
  • Ying H, Zou Y, Yu W, et al. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser. J Dermatol. 2017;44(6):660–665. doi:10.1111/1346-8138.13747
  • Zeng M, Shen S, Chen W, Yang C, Liu S. Superficial hemangioma is better treated by topical 5-aminolevulinic followed by 595-nm pulsed dye laser therapy rather than 595-nm laser therapy alone. Lasers Med Sci. 2017;32(8):1889–1893. doi:10.1007/s10103-017-2304-9
  • Lin MY, Lin CS, Hu S, et al. The application of 595-nm pulsed dye laser for vascular anomalies in a Chinese population: a 10-year experience. J Cosmet Laser Ther. 2019;21(3):171–178. doi:10.1080/14764172.2018.1502450
  • Yang MU, Yaroslavsky AN, Farinelli WA, et al. Long-pulsed neodymium: yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol. 2005;52(3 Pt 1):480–490. doi:10.1016/j.jaad.2004.10.876
  • Ross EV, Meehan KJ, Gilbert S, Domankevitz Y. Optimal pulse durations for the treatment of leg telangiectasias with an alexandrite laser. Lasers Surg Med. 2009;41(2):104–109. doi:10.1002/lsm.20737
  • Wu Q, Shi Q, Long J, et al. [Usage and efficacy of timolol maleate eye drops in treatment of superficial infantile hemangioma]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42(6):657–661. Chinese.